Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Support us
Support us
  • Home
  • Thomas Eleveld

Thomas Eleveld

Postdoc
--
Phone 088 97 25 614
Email t.f.eleveld@prinsesmaximacentrum.nl

--

Publications

11 publications in total

  • Translation research on testicular germ cell tumors.

    • jun. 2023
    • Thomas, Eleveld, et al
    • Tijdschrift voor Urologie

  • MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

    • jan. 2023
    • Thomas F, Eleveld, et al
    • Frontiers in Oncology

  • Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma

    • sep. 2022
    • Kaylee M., Keller, et al
    • Frontiers in Oncology

  • Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors

    • apr. 2022
    • Dennis M, Timmerman, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology

  • Engineering large-scale chromosomal deletions by CRISPR-Cas9

    • dec. 2021
    • Thomas F, Eleveld, et al
    • Nucleic acids research
View all publications